Hosted on MSN9mon
The Alfred begins eye-tracking trial for improved neurological careepilepsy, and multiple sclerosis, to assess their brain functions via BrainEye’s 60-second eye movement test, the hospital said in a statement. The collected data will be compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback